Evidence map›Paper›PMID 30962570›Full record

ArticleNature microbiology2019

A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance.

José-María López-Lozano, Timothy Lawes, César Nebot, Arielle Beyaert, Xavier Bertrand, Didier Hocquet, Mamoon Aldeyab, Michael Scott, Geraldine Conlon-Bingham, David Farren and 7 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Nature microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Global Trends in Antimicrobial Resistance-Related Mortality fromTropical medicine and infectious disease · 2026
    Article
  3. Article
  4. Article
  5. A One Health Comparative Study of MDRAntibiotics (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. [Antibiotic stewardship programs in the Spanish emergency services: PROA-URG Study].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2024
    Article
  15. Article
  16. Article
  17. Observational
  18. Challenges in Forecasting Antimicrobial Resistance.Emerging infectious diseases · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

José-María López-LozanoMedicine Preventive-Infection Control Team, Hospital Vega Baja, Orihuela, Spain.
Timothy LawesThe Wellcome Trust Liverpool-Glasgow Centre for Global Health Research, Liverpool, UK. t.lawes@nhs.net.ORCID http://orcid.org/0000-0003-4393-245X
César NebotCentro Universitario de la Defensa de San Javier, Murcia, Spain.
Arielle BeyaertDepartamento de Métodos Cuantitativos para la Economía y la Empresa, University of Murcia, Murcia, Spain.
Xavier BertrandLaboratoire Chrono-environnement, Université de Bourgogne-Franche-Comté, Besançon, France.
Didier HocquetLaboratoire Chrono-environnement, Université de Bourgogne-Franche-Comté, Besançon, France.
Mamoon AldeyabSchool of Pharmacy and Pharmaceutical Science, Ulster University, Coleraine, UK.
Michael ScottPharmacy Department, Northern Health and Social Care Trust and Regional Medicines Optimisation Innovation Centre, Antrim, UK.
Geraldine Conlon-BinghamPharmacy Department, Northern Health and Social Care Trust and Regional Medicines Optimisation Innovation Centre, Antrim, UK.
David FarrenDepartment of Medical Microbiology, Antrim Area Hospital, Antrim, UK.
Gábor KardosDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Adina FésűsClinical Pharmacy, University of Debrecen, Debrecen, Hungary.
Jesús Rodríguez-BañoInfectious Diseases and Clinical Microbiology Unit, Hospital Universitario Virgen Macarena, Seville, Spain.
Pilar RetamarInfectious Diseases and Clinical Microbiology Unit, Hospital Universitario Virgen Macarena, Seville, Spain.
Nieves Gonzalo-JiménezMedical Microbiology Department, Hospital Vega Baja, Orihuela, Spain.
Ian M GouldMedical Microbiology Department, Aberdeen Royal Infirmary, Aberdeen, UK.
THRESHOLDS study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Balancing access to antibiotics with the control of antibiotic resistance is a global public health priority. At present, antibiotic stewardship is informed by a 'use it and lose it' principle, in which antibiotic use by the population is linearly related to resistance rates. However, theoretical and mathematical models suggest that use-resistance relationships are nonlinear. One explanation for this is that resistance genes are commonly associated with 'fitness costs' that impair the replication or transmissibility of the pathogen. Therefore, resistant genes and pathogens may only gain a survival advantage where antibiotic selection pressures exceed critical thresholds. These thresholds may provide quantitative targets for stewardship-optimizing the control of resistance while avoiding over-restriction of antibiotics. Here, we evaluated the generalizability of a nonlinear time-series analysis approach for identifying thresholds using historical prescribing and microbiological data from five populations in Europe. We identified minimum thresholds in temporal relationships between the use of selected antibiotics and incidence rates of carbapenem-resistant Acinetobacter baumannii (Hungary), extended-spectrum β-lactamase-producing Escherichia coli (Spain), cefepime-resistant E. coli (Spain), gentamicin-resistant Pseudomonas aeruginosa (France) and methicillin-resistant Staphylococcus aureus (Northern Ireland) in different epidemiological phases. Using routinely generated data, our approach can identify context-specific quantitative targets for rationalizing population antibiotic use and controlling resistance. Prospective intervention studies that restrict antibiotic consumption are needed to validate these thresholds.

Indexed as

Drug Resistance, BacterialAcinetobacter baumanniiAnti-Bacterial AgentsAntimicrobial StewardshipBacterial InfectionsBacterial ProteinsEscherichia coliEuropeHumansIncidenceMethicillin-Resistant Staphylococcus aureusModels, TheoreticalPseudomonas aeruginosaTime FactorsAnti-Bacterial AgentsBacterial Proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.